Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
In the last 90 days, Nuvectis Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Nuvectis Pharma, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +1 vs. Q1 2024
- Shares held
- 1.21M
- −356.9K (−22.8%) vs. Q1 2024
- Total value
- $7.63M
- −$5.18M (−40.4%) vs. Q1 2024
- New holders
- 17
- 10 more added
- Sold out
- 16
- 12 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $189.0M |
| Q1 2026 | 62 | $34.9M |
| Q4 2025 | 48 | $32.0M |
| Q3 2025 | 53 | $22.2M |
| Q2 2025 | 47 | $24.2M |
| Q1 2025 | 33 | $20.0M |
| Q4 2024 | 31 | $7.15M |
| Q3 2024 | 31 | $6.60M |
| Q2 2024 | 41 | $7.63M |
| Q1 2024 | 40 | $12.8M |
| Q4 2023 | 36 | $12.6M |
| Q3 2023 | 33 | $16.5M |
| Q2 2023 | 37 | $20.0M |
| Q1 2023 | 13 | $6.34M |
| Q4 2022 | 11 | $7.38M |
| Q3 2022 | 12 | $10.0M |
| Q2 2022 | 11 | $7.20M |
| Q1 2022 | 8 | $4.65M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Nuvectis Pharma, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 251,138 | $1.59M | 0.00% | −47,662−16.0% | Reduced |
| Baldwin Brothers Inc | 168,630 | $1.07M | 0.08% | +14,500+9.4% | Added |
| Millennium Management LLC | 119,459 | $756.2K | 0.00% | +79,958+202.4% | Added |
| BlackRock Inc. | 83,412 | $528.0K | 0.00% | −289,309−77.6% | Reduced |
| Renaissance Technologies LLC | 74,500 | $471.6K | 0.00% | +12,800+20.7% | Added |
| Goldman Sachs Group Inc | 61,570 | $389.7K | 0.00% | +61,570 | New |
| Geode Capital Management, LLC | 53,227 | $337.0K | 0.00% | −81,301−60.4% | Reduced |
| Northern Trust Corp | 49,827 | $315.4K | 0.00% | −12,270−19.8% | Reduced |
| Gsa Capital Partners LLP | 48,339 | $306.0K | 0.02% | +9,057+23.1% | Added |
| Forbes J M & Co LLP | 47,419 | $300.2K | 0.03% | +13,419+39.5% | Added |
| Marshall Wace, LLP | 33,868 | $214.4K | 0.00% | −16,200−32.4% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 23,173 | $146.7K | 0.01% | +23,173 | New |
| Edmond de Rothschild Holding S.A. | 19,170 | $121.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 17,021 | $107.7K | 0.00% | +17,021 | New |
| State Street Corp | 15,300 | $96.8K | 0.00% | −114,079−88.2% | Reduced |
| Citadel Advisors LLC | 14,937 | $94.6K | 0.00% | +14,937 | New |
| JPMorgan Chase & Co | 14,753 | $93.4K | 0.00% | +9,588+185.6% | Added |
| HRT Financial LP | 13,627 | $86.0K | 0.00% | +13,627 | New |
| Centiva Capital, LP | 13,300 | $84.2K | 0.00% | +13,300 | New |
| Two Sigma Investments, LP | 13,044 | $82.6K | 0.00% | +13,044 | New |
| Baxter Bros Inc | 12,500 | $79.1K | 0.01% | +12,500 | New |
| Morgan Stanley | 10,198 | $64.6K | 0.00% | −30,993−75.2% | Reduced |
| Point72 Asia (Singapore) Pte. Ltd. | 9,203 | $58.3K | 0.01% | +9,203 | New |
| Barclays PLC | 8,270 | $52.3K | 0.00% | −2,023−19.7% | Reduced |
| Qube Research & Technologies Ltd | 7,978 | $50.5K | 0.00% | +7,978 | New |
| Tower Research Capital LLC (TRC) | 5,996 | $38.0K | 0.00% | +5,145+604.6% | Added |
| Citigroup Inc | 4,883 | $30.9K | 0.00% | +3,501+253.3% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 3,254 | $20.6K | 0.00% | +3,254 | New |
| Rhumbline Advisers | 1,871 | $11.8K | 0.00% | −5,631−75.1% | Reduced |
| Point72 (DIFC) Ltd | 1,249 | $7.91K | 0.00% | +1,249 | New |
| FMR LLC | 971 | $6.15K | 0.00% | +536+123.2% | Added |
| Catalyst Funds Management Pty Ltd | 900 | $5.70K | 0.00% | +900 | New |
| Bank of America Corp | 764 | $4.84K | 0.00% | −3,011−79.8% | Reduced |
| Macquarie Group Ltd | 355 | $2.25K | 0.00% | +355 | New |
| Hollencrest Capital Management | 280 | $1.77K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 212 | $1.34K | 0.00% | +212 | New |
| NBC Securities, Inc. | 300 | $1.00K | 0.00% | +200+200.0% | Added |
| Steward Partners Investment Advisory, LLC | 100 | $633 | 0.00% | +100 | New |
| New York State Common Retirement Fund | 64 | $405 | 0.00% | −5,685−98.9% | Reduced |
| UBS Group AG | 13 | $82 | 0.00% | −7,607−99.8% | Reduced |
| CWM, LLC | 16 | $0 | 0.00% | +16 | New |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −19,920−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −17,755−100.0% | Sold out |
| Blue Zone Wealth Advisors, LLC | 0 | $0 | 0.00% | −14,350−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −11,883−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −5,800−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −3,664−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −3,509−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −841−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −747−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −566−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −231−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |